198
Participants
Start Date
January 23, 2025
Primary Completion Date
July 10, 2027
Study Completion Date
July 10, 2027
Placebo
placebo subcutaneous injection Q2W until week 46.
placebo
placebo subcutaneous injection Q3W until week 45.
The Second Affiliated Hospital of Wannan Medical College, Wuhu
Peking University People's Hospital, Beijing
Chongqing Traditional Chinese Medicine Hospital, Chongqing
The First Affiliated Hospital of Chongqing Medical University, Chongqing
Dongguan People's Hospital, Dongguan
Dermatology Hospital of Southern Medical University, Guangzhou
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
The First Affiliated Hospital of Jinan University, Guangzhou
The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou
Jiangmen Central Hospital, Jiangmen
The University of Hong Kong - Shenzhen Hospital, Shenzhen
The Third People's Hospital of Zhuhai, Zhuhai
Liuzhou Worker's Hospital, Liuzhou
Jinzhou Central Hospital, Jinzhou
Tongji Hospital, Wuhan
Hunan Children's Hospital, Changsha
XiangYa Hospital CentralSouth University, Changsha
Affiliated Hospital of Jiangsu University, Zhenjiang
Dermatology Hospital of Jiangxi Province, Nanchang
Shandong Provincial Dermatology Hospital, Jinan
Jining First People's Hospital, Jining
Huashan Hospital, Fudan University, Shanghai
Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai
Shanghai Skin Disease Hospital, Shanghai
The First Affiliated Hospital of Xi'an Jiao Tong University, Xi’an
Sichuan Provincial People's Hospital, Chengdu
The First Affiliated Hospital of Kunming Medical University, Kunming
The First Hospital of Jiaxing, Jiaxing
Lead Sponsor
Akeso
INDUSTRY